BioMarin Pharmaceutical (BMRN) News Today $57.21 -1.02 (-1.75%) As of 11:58 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock BMRN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst SaysJuly 14 at 12:16 PM | marketbeat.com5,380 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Asahi Life Asset Management CO. LTD.July 14 at 8:44 AM | marketbeat.comWealthTrust Asset Management LLC Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 12 at 6:26 AM | marketbeat.comLbp Am Sa Buys 6,576 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 11, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.61 Consensus PT from BrokeragesJuly 11, 2025 | americanbankingnews.comBioMarin Pharmaceutical (BMRN) Finalizes the Acquisition of Inozyme PharmaJuly 10, 2025 | msn.comCFO4Life Group LLC Buys Shares of 7,913 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 10, 2025 | marketbeat.comStratos Wealth Advisors LLC Has $2.52 Million Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 9, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Average Recommendation of "Moderate Buy" from BrokeragesJuly 8, 2025 | marketbeat.comTeacher Retirement System of Texas Trims Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 6, 2025 | marketbeat.comKeybank National Association OH Sells 21,892 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 5, 2025 | marketbeat.comMorgan Stanley Initiates Coverage on BioMarin Pharmaceutical (NASDAQ:BMRN)July 3, 2025 | marketbeat.comPositive Outlook for BioMarin Pharmaceutical Amid Competitive Challenges and Market Expansion OpportunitiesJuly 3, 2025 | tipranks.comKBC Group NV Has $8.86 Million Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 2, 2025 | marketbeat.comOppenheimer & Co. Inc. Takes $383,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)July 2, 2025 | marketbeat.comBioMarin Announces Completion of Acquisition of InozymeJuly 1, 2025 | prnewswire.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.June 30, 2025 | marketbeat.comBioMarin’s ROCTAVIAN Shows Sustained Efficacy, Safety Over 5 Years for Severe Hemophilia AJune 28, 2025 | msn.comWealth Enhancement Advisory Services LLC Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 28, 2025 | marketbeat.comAlta Wealth Advisors LLC Acquires New Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 27, 2025 | marketbeat.comBioMarin Pharmaceutical’s Growth Potential and Competitive Edge Amidst Market ChallengesJune 27, 2025 | tipranks.comThe Top 5 Analyst Questions From BioMarin Pharmaceutical’s Q1 Earnings CallJune 26, 2025 | msn.comKentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 26, 2025 | marketbeat.com12,890 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Kentucky Retirement SystemsJune 25, 2025 | marketbeat.comBMRN BioMarin Pharmaceutical Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comBMRN - BioMarin Pharmaceutical Inc Key Metrics - MorningstarJune 24, 2025 | morningstar.comMBioMarin reports new data underscoring the long-term efficacy of ROCTAVIANJune 24, 2025 | msn.comBioMarin Presents Five-Year Phase 3 Results Reinforcing Long-Term Efficacy and Safety of ROCTAVIAN® (valoctocogene roxaparvovec-rvox) at International Society on Thrombosis and Haemostasis 2025 CongressJune 24, 2025 | prnewswire.com2 Reasons to Watch BMRN and 1 to Stay CautiousJune 23, 2025 | msn.comBarclays Initiates BioMarin Pharmaceutical Inc. (BMRN) with a Buy RatingJune 23, 2025 | insidermonkey.comCovea Finance Buys 29,200 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 21, 2025 | marketbeat.comDoes The Market Have A Low Tolerance For BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Mixed Fundamentals?June 20, 2025 | finance.yahoo.comNorthCrest Asset Manangement LLC Purchases New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 16, 2025 | marketbeat.comJim Cramer on BioMarin: “I Don’t Think It Works Now”June 15, 2025 | msn.comHandelsbanken Fonder AB Raises Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 14, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives Consensus Rating of "Moderate Buy" from BrokeragesJune 13, 2025 | marketbeat.com8,940 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Purchased by Davis Investment Partners LLCJune 12, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Assenagon Asset Management S.A.June 12, 2025 | marketbeat.comBioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Holdings Lifted by Avanza Fonder ABJune 12, 2025 | marketbeat.comResearch Analysts Issue Forecasts for BMRN FY2026 EarningsJune 10, 2025 | marketbeat.comBioMarin Pharmaceutical: Hold Rating Maintained Amid Competitive Pressures and New Data InsightsJune 10, 2025 | tipranks.comPallas Capital Advisors LLC Buys 22,527 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 10, 2025 | marketbeat.comToth Financial Advisory Corp Raises Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 10, 2025 | marketbeat.comWesbanco Bank Inc. Makes New Investment in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 10, 2025 | marketbeat.comMerit Financial Group LLC Has $1.47 Million Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 7, 2025 | marketbeat.comGAMMA Investing LLC Boosts Stock Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 7, 2025 | marketbeat.comWealth Enhancement Advisory Services LLC Purchases 17,340 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 7, 2025 | marketbeat.comHere Are All 6 Stocks I've Bought Through 5 Months of 2025June 5, 2025 | fool.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)June 1, 2025 | marketbeat.comSummit Global Investments Purchases New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)May 31, 2025 | marketbeat.com Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address BMRN Media Mentions By Week BMRN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BMRN News Sentiment▼1.190.99▲Average Medical News Sentiment BMRN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BMRN Articles This Week▼1012▲BMRN Articles Average Week Get BioMarin Pharmaceutical News Delivered to You Automatically Sign up to receive the latest news and ratings for BMRN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ALNY News Today BIIB News Today UTHR News Today INCY News Today NBIX News Today EXEL News Today EXAS News Today RGEN News Today HALO News Today IONS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BMRN) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioMarin Pharmaceutical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioMarin Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.